stoxline Quote Chart Rank Option Currency Glossary
  
Medifast, Inc. (MED)
24.8  1.97 (8.63%)    05-28 16:00
Open: 22.99
High: 24.94
Volume: 822,744
  
Pre. Close: 22.83
Low: 22.7
Market Cap: 271(M)
Technical analysis
2024-05-28 4:24:01 PM
Short term     
Mid term     
Targets 6-month :  36.17 1-year :  42.39
Resists First :  30.97 Second :  36.29
Pivot price 24.82
Supports First :  22.35 Second :  18.59
MAs MA(5) :  23.86 MA(20) :  25.2
MA(100) :  40.18 MA(250) :  63.94
MACD MACD :  -2.2 Signal :  -2.3
%K %D K(14,3) :  20.8 D(3) :  13.4
RSI RSI(14): 39.9
52-week High :  109.51 Low :  22.35
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MED ] has closed above bottom band by 49.2%. Bollinger Bands are 63.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 24.97 - 25.07 25.07 - 25.17
Low: 22.47 - 22.57 22.57 - 22.67
Close: 24.62 - 24.8 24.8 - 24.96
Company Description

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Headline News

Fri, 24 May 2024
Medifast: Significant Undervaluation Even As Struggles Persist (NYSE:MED) - Seeking Alpha

Fri, 24 May 2024
Lacklustre Performance Is Driving Medifast, Inc.'s (NYSE:MED) 32% Price Drop - Simply Wall St

Fri, 24 May 2024
At US$22.76, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely? - Simply Wall St

Wed, 01 May 2024
Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript - Yahoo Finance

Tue, 30 Apr 2024
Why Is Medifast (MED) Stock Down 20% Today? - InvestorPlace

Mon, 29 Apr 2024
Medifast Inc (MED) Q1 2024 Earnings: Revenue Declines Amid Market Challenges - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Consumer Cyclical
Industry:
Personal Products & Services
Shares Out 11 (M)
Shares Float 10 (M)
Held by Insiders 2.6 (%)
Held by Institutions 91.5 (%)
Shares Short 3,120 (K)
Shares Short P.Month 2,660 (K)
Stock Financials
EPS 6.19
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 19.72
Profit Margin 7.5 %
Operating Margin 5.2 %
Return on Assets (ttm) 16.4 %
Return on Equity (ttm) 35.4 %
Qtrly Rev. Growth -50 %
Gross Profit (p.s.) 0
Sales Per Share 82.06
EBITDA (p.s.) 8.73
Qtrly Earnings Growth -79.4 %
Operating Cash Flow 91 (M)
Levered Free Cash Flow 57 (M)
Stock Valuations
PE Ratio 4
PEG Ratio 1.6
Price to Book value 1.25
Price to Sales 0.3
Price to Cash Flow 2.98
Stock Dividends
Dividend 1.64
Forward Dividend 0
Dividend Yield 6.6%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android